Gene Gene synonym Ensembl Gene description Chromosome Position Protein class Evidence HPA evidence UniProt evidence MS evidence Antibody Reliability (IH) Reliability (Mouse Brain) Reliability (IF) Subcellular location RNA tissue category RNA TS RNA TS TPM TPM max in non-specific
KCNK1 DPK, K2p1.1, TWIK-1 ENSG00000135750 Potassium channel, two pore domain subfamily K, member 1 1 233614004-233672512 Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA016049, CAB022588 Approved Approved Vesicles Mixed cerebral cortex: 46.6
KCNK12 K2p12.1, THIK-2, THIK2 ENSG00000184261 Potassium channel, two pore domain subfamily K, member 12 2 47516581-47570939 Predicted membrane proteins, Voltage-gated ion channels Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enriched 16 cerebral cortex: 5.3 testis: 0.3
KCNK13 K2p13.1, THIK-1, THIK1 ENSG00000152315 Potassium channel, two pore domain subfamily K, member 13 14 90061765-90185857 Predicted membrane proteins, Voltage-gated ion channels Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA003514 Approved Approved Nuclear speckles
Cell Junctions Tissue enhanced 0 parathyroid gland: 14.3;testis: 14.4 kidney: 3.3
KCNK15 dJ781B1.1, K2p15.1, KCNK11, KCNK14, KIAA0237, KT3.3, TASK-5, TASK5 ENSG00000124249 Potassium channel, two pore domain subfamily K, member 15 20 44745780-44752313 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA064861 Uncertain Tissue enhanced 0 fallopian tube: 8.0 testis: 2.9
KCNK16 K2p16.1, TALK-1, TALK1 ENSG00000095981 Potassium channel, two pore domain subfamily K, member 16 6 39314698-39322968 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 duodenum: 3.9;pancreas: 5.4;stomach: 12.6 thyroid gland: 1.7
KCNK17 K2p17.1, TALK-2, TALK2, TASK-4, TASK4 ENSG00000124780 Potassium channel, two pore domain subfamily K, member 17 6 39299001-39314553 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA043892 Uncertain Tissue enhanced 0 lung: 5.6 placenta: 5.2
KCNK18 K2p18.1, TRESK, TRESK-2, TRESK2, TRIK ENSG00000186795 Potassium channel, two pore domain subfamily K, member 18 10 117197489-117210299 Disease related genes, Potential drug targets, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level No evidence Evidence at protein level HPA044739 Uncertain Not detected testis: 0.2
KCNK2 K2p2.1, TREK-1 ENSG00000082482 Potassium channel, two pore domain subfamily K, member 2 1 215005775-215237093 FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA056054 Uncertain Approved Mitochondria
Cytosol Tissue enhanced 0 adrenal gland: 75.5 thyroid gland: 17.3
KCNK3 K2p3.1, TASK, TASK-1 ENSG00000171303 Potassium channel, two pore domain subfamily K, member 3 2 26692690-26733420 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 adrenal gland: 112.3;placenta: 35.5 lung: 19.9
KCNK4 K2p4.1, TRAAK ENSG00000182450 Potassium channel, two pore domain subfamily K, member 4 11 64291302-64300031 Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enriched 12 cerebral cortex: 4.3 cervix: 0.3
KCNK5 K2p5.1, TASK-2 ENSG00000164626 Potassium channel, two pore domain subfamily K, member 5 6 39188973-39229450 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA059148 Uncertain Approved Nucleus Tissue enhanced 0 small intestine: 40.1 gallbladder: 29.6
KCNK6 K2p6.1, TWIK-2 ENSG00000099337 Potassium channel, two pore domain subfamily K, member 6 19 38319844-38332076 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level CAB022637, HPA040184 Uncertain Approved Plasma membrane
Actin filaments
Cytosol Mixed endometrium: 22.8
KCNK7 K2p7.1 ENSG00000173338 Potassium channel, two pore domain subfamily K, member 7 11 65592855-65595996 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Voltage-gated ion channels Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA077577 Approved Plasma membrane Tissue enriched 7 skin: 53.1 esophagus: 8.0
KCNK9 K2p9.1, TASK-3, TASK3 ENSG00000169427 Potassium channel, two pore domain subfamily K, member 9 8 139600838-139703056 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 7 adrenal gland: 4.8;cerebral cortex: 4.8 cervix: 0.7